Related Experiment Video
Updated: Jun 21, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Combined therapy in the treatment of hypertension
Carlos Escobar1, Vivencio Barrios
1Department of Cardiology, Hospital Infanta Sofia, Madrid, Spain.
Insights
Most patients with hypertension require combination therapy for effective blood pressure control. This study reviews evidence on the efficacy and tolerability of using multiple antihypertensive agents together.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Hypertension management often necessitates multiple antihypertensive agents to reach blood pressure (BP) goals.
- European guidelines advocate for combination therapy when monotherapy is insufficient or as a primary treatment for high-risk individuals, very high BP, or stringent BP targets (<130/80 mmHg).
Purpose of the Study:
- To update the available evidence on the efficacy and tolerability of combined antihypertensive therapy.
Main Methods:
- Review of existing scientific literature and clinical evidence.
- Analysis of studies focusing on the combined use of different antihypertensive drug classes.
Main Results:
- Combined therapy offers earlier and more significant BP reduction due to complementary mechanisms of action.
- Combination therapy can lead to a lower incidence of side effects, potentially by mitigating compensatory responses and allowing for lower individual drug doses.
Conclusions:
- Combined antihypertensive therapy is a well-established and effective strategy for managing hypertension.
- The benefits include enhanced efficacy and improved tolerability, supporting its use in various clinical scenarios.
Abstract:
The majority of patients with hypertension need at least two antihypertensive agents to achieve blood pressure (BP) objectives. As current European guidelines for the treatment of arterial hypertension recommend, combined therapy is required when monotherapy fails and as a first-line treatment in certain situations, such as subjects at high or very high cardiovascular risk, markedly elevated BP values, or when lower targets are required (<130/80 mmHg). The advantages of combined therapy are well known and include an earlier and higher antihypertensive efficacy because of complementary mechanisms of action, and a lower incidence of side effects due to the possible compensatory responses and, in many cases, the lower doses used. In the present study, available evidence about the efficacy and tolerability of combined therapy for the treatment of hypertension is updated.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension V: Nursing Management
Heart Failure V: Medical Management
Drug Therapy
Antianxiety Medications